These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6117576)

  • 1. Single-dose study of nabilone in anxious volunteers.
    Glass RM; Uhlenhuth EH; Hartel FW; Schuster CR; Fischman MW
    J Clin Pharmacol; 1981; 21(S1):383S-396S. PubMed ID: 6117576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single dose study of nabilone, a synthetic cannabinoid.
    Glass RM; Uhlenhuth EH; Hartel FW; Schuster CR; Fischman MW
    Psychopharmacology (Berl); 1980; 71(2):137-42. PubMed ID: 6108592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for evaluation of antianxiety drugs with the use of experimentally induced stress: Comparison of nabilone and diazepam.
    Nakano S; Gillespie HK; Hollister LE
    Clin Pharmacol Ther; 1978 Jan; 23(1):54-62. PubMed ID: 22419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
    Bedi G; Cooper ZD; Haney M
    Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
    Lile JA; Kelly TH; Hays LR
    Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of nabilone, a cannabinol derivative.
    Lemberger L; Rowe H
    Clin Pharmacol Ther; 1975 Dec; 18(6):720-6. PubMed ID: 1204278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety.
    Fabre LF; McLendon D
    J Clin Pharmacol; 1981; 21(S1):377S-382S. PubMed ID: 6117575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic and antihyperalgesic effects of nabilone on experimental heat pain.
    Redmond WJ; Goffaux P; Potvin S; Marchand S
    Curr Med Res Opin; 2008 Apr; 24(4):1017-24. PubMed ID: 18302810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
    Jetly R; Heber A; Fraser G; Boisvert D
    Psychoneuroendocrinology; 2015 Jan; 51():585-8. PubMed ID: 25467221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nabilone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A; Holmes B
    Drugs; 1985 Aug; 30(2):127-44. PubMed ID: 2863127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bronchial effects of nabilone and terbutaline in healthy and asthmatic subjects.
    Gong H; Tashkin DP; Calvarese B
    J Clin Pharmacol; 1983 Apr; 23(4):127-33. PubMed ID: 6306060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].
    Pinsger M; Schimetta W; Volc D; Hiermann E; Riederer F; Pölz W
    Wien Klin Wochenschr; 2006 Jun; 118(11-12):327-35. PubMed ID: 16855921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.
    Wissel J; Haydn T; Müller J; Brenneis C; Berger T; Poewe W; Schelosky LD
    J Neurol; 2006 Oct; 253(10):1337-41. PubMed ID: 16988792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.
    Mendelson JH; Mello NK
    Psychopharmacology (Berl); 1984; 83(4):351-6. PubMed ID: 6149589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A species comparison of the toxicity of nabilone, a new synthetic cannabinoid.
    Hanasono GK; Sullivan HR; Gries CL; Jordan WH; Emmerson JL
    Fundam Appl Toxicol; 1987 Aug; 9(2):185-97. PubMed ID: 2888699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
    Ahmedzai S; Carlyle DL; Calder IT; Moran F
    Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia.
    Fox SH; Kellett M; Moore AP; Crossman AR; Brotchie JM
    Mov Disord; 2002 Jan; 17(1):145-9. PubMed ID: 11835452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of oral dronabinol during opioid withdrawal in humans.
    Jicha CJ; Lofwall MR; Nuzzo PA; Babalonis S; Elayi SC; Walsh SL
    Drug Alcohol Depend; 2015 Dec; 157():179-83. PubMed ID: 26483357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of nabilone and cannabidiol on binocular depth inversion in Man.
    Leweke FM; Schneider U; Radwan M; Schmidt E; Emrich HM
    Pharmacol Biochem Behav; 2000 May; 66(1):175-81. PubMed ID: 10837858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.